STOCKHOLM, July 11, 2019 /PRNewswire/ -- RaySearch has received 510(k) clearance from the FDA in the USA for version 8B of the treatment planning system RayStation®. RayStation 8B was released in December 2018 and includes the first machine le

UPPSALA, Sweden, July 11, 2019 /PRNewswire/ -- Q2 2019 highlightsTotal net revenues of SEK 201.2 million (199.7), up 0.8 percent and 19.1 percent when excluding ex-US milestone payment of SEK 30.8 million in Q2 2018 Zubsolv® US net revenues of

STOCKHOLM, July 11, 2019 /PRNewswire/ -- Significant events April-JuneJanssen presented data from the clinical Phase I study with ADC-1013 indicates good safety and shows initial signs of clinical effect. Study design and progress for the ongoing ATOR-1015 Phase I study showcased at ASCO. Clinical trial

STOCKHOLM, July 11, 2019 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that presentations related to BAN2401 will be given at the Alzheimer's Association International Conference® 2019 (AAIC®) to be held July 14-18 in Los Angeles, USA.

STOCKHOLM, July 11, 2019 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that presentations related to BAN2401 will be given at the Alzheimer's Association International Conference® 2019 (AAIC®) to be held July 14-18 in Los Angeles, USA.

CHENGDU, China, July 11, 2019 /PRNewswire/ -- On July 10th, Chengdu Hi-tech Zone and Gilead Sciences inked a strategic cooperation agreement on the Gilead Sciences Western China Operation Center project, which marked the official registration of its western China operation center in Chengdu Hi-tech Zone.

MANHASSET, N.Y., July 10, 2019 /PRNewswire/ -- Theodoros Zanos, PhD, head of the Ne

AQUEBOGUE, N.Y., July 10, 2019 /PRNewswire/ -- Altaire Pharmaceuticals, Inc., announces today that it is voluntarily recalling the Over-the-Counter (OTC) drug products and lots, within expiry, sold at CVS Health  the during the time period as indicated in the tables below.  As a precautionary measure, Altaire is voluntarily initiating the recall due to man

NEW YORK, July 10, 2019 /PRNewswire/ -- Aflac Global Investments announced today that it has hired Stephen Scott as managing director; chief financial officer of Aflac Global Investments, reporting to Eric M. Kirsch, executive vice president and global chief investment officer of Aflac Incorporated and preside

CLEVELAND, July 10, 2019 /PRNewswire/ -- Global healthcare expenditures are projected to rise 3.7% annually in real (inflation-adjusted) US dollars through 2023, according to Global Healthcare, a report recently released by Freedonia Focus Reports. Spending will be driven by increasing access to a myriad of healthcare services in low and middle income